Anti-proliferative effect of Rosmarinus officinalis L. extract on human melanoma A375 cells

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Cattaneo, Lucia ^a   Cicconi, Rosella ^a   Mignogna, Giuseppina ^b   Giorgi, Alessandra ^b   Mattei, Maurizio ^a   Graziani, Giulia ^c   Ferracane, Rosalia ^c   Grosso, Alessandro ^a   Aducci, Patrizia ^a   Schininà, M Eugenia ^b   Marra, Mauro ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE; ROSMARINUS OFFICINALIS EXTRACT; ABIETANE DERIVATIVE; ANTINEOPLASTIC AGENT; APIGENIN; CARNOSOL; GLUCURONIC ACID; LUTEOLIN; PLANT EXTRACT; SCUTELLARIN;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG IDENTIFICATION; ELECTROSPRAY MASS SPECTROMETRY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MOUSE; MTT ASSAY; NONHUMAN; OXIDATION REDUCTION STATE; PROTEIN ANALYSIS; PROTEIN CARBONYLATION; PROTEOMICS; TRYPAN BLUE ASSAY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; MELANOMA; METABOLISM; OXIDATIVE STRESS; ROSMARINUS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APIGENIN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DITERPENES, ABIETANE; DRUG SCREENING ASSAYS, ANTITUMOR; GLUCURONATES; HUMANS; LUTEOLIN; MELANOMA; OXIDATIVE STRESS; PLANT EXTRACTS; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES; ROSMARINUS;

EID: 84941365952     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132439     Document Type: Article

References (67)

1. Al Sereiti MR, Abu-Amer KM, Sen P. (1999). Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol 37: 124-130. PMID: 10641130
2. Sotelo-Félix JI, Martinez-Fong D, Muriel P, Santillan RL, Castillo D, Yahuaca P. (2002). Evaluation of the effectiveness of Rosmarinus officinalis (Lamiaceae) in the alleviation of carbon tetrachlorideinduced acute hepatotoxicity in the rat. J. Ethnopharmacol 81: 145-154. PMID: 12065145
3. Gutiérrez R, Alvarado JL, Presno M, Pérez-Veyna O, Serrano CJ, Yahuaca P. (2010) Oxidative stress modulation by Rosmarinus officinalis in CCL4-induced liver cirrhosis. Phytoter Res 24: 595-601.
4. Yamamoto J, Yamada K, Naemura A, Yamashita T, Arai R. (2005) Testing various herbs for antithrombotic effect. Nutrition 21: 580-587. PMID: 15850964
5. Dias PC, Foglio MA, Possenti A, de Carvalho JE. (2000) Antiulcerogenic activity of crude hydroalcoholic extract of Rosmarinus officinalis L. Etnopharmacol 69: 57-62.
6. Bakirel T, Bakirel U, Keles OU, Ulgen SG. Yardibi H. (2008) In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits. J Etnopharmacol 116: 64-73.
7. Gonzalez-Trujano ME, Pena EI, Martinez AL, Moreno J, Guevara-Fefer P, Dèciga-Campos M, et al. (2007) Evaluation of the antinociceptive effect of Rosmarinus officinalis L. using three different experimental models in rodent. J Etnopharmacol 111: 476-482.
8. Bozin B, Mimica-Dukic N, Samojlik L, Jovin E. (2007) Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J Agric Food Chem 55: 7879-7885. PMID: 17708648
9. Kontogianni VG, Tomic G, Nikolic I, Nerantzaki AA, Sayyad N, Stosic-Grujicic S, et al. (2013) Phytochemical profile of Rosmarinus officinalis and Salvia officinalis extracts and correlation to their antioxidant and anti-proliferative activity. Food Chem 136:120-9. doi: 10.1016/j.foodchem.2012.07.091 PMID: 23017402
10. Bai N, He K, Roller M, Lai C-S, Shao X, Pan M-H, et al. (2010) Flavonoids and phenolic compounds from Rosmarinus officinalis. J Agr Food Chem. 58: 5363-5367.
11. Cheung S, TaI J. (2007) Anti-proliferative and antioxidant properties of rosemary (Rosmarinus officinalis). Oncology Reports 17: 1525-1531. PMID: 17487414
12. Yesil-Celiktas O, Sevimli C, Bedir E, Vardar-Sukan F. (2010) inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines. Plant Foods Hum Nutr 65: 158-163. doi: 10.1007/s11130-010-0166-4 PMID: 20449663
13. Johnson JJ. (2011) Carnosol a promising anti-cancer and anti-inflammatory agent. Cancer Letters 305: 1-7. doi: 10.1016/j.canlet.2011.02.005 PMID: 21382660
14. Xavier CPR, Lima CF, Fernandes-Ferreira M, Pereira-Wilson C. (2009) Salvia fruticosa, salvia officinalis, and rosmarinic acid induce apoptosis and inhibit proliferation of human colorectal cell lines: the role in MAPK/ERK pathway. Nutrition and Cancer 61: 564-571. doi: 10.1080/01635580802710733 PMID: 19838929
15. Wei FX, Liu JX, Wang L, Li HZ, Luo JB. (2008) Expression of bcl-2 and bax genes in the liver cancer cell line HepG2 after apoptosis induced by essential oils from Rosmarinus officinalis. Zhong Yao Cai, 31: 877-879. PMID: 18998574
16. Steiner M, Priel I, Giat J, Levy J, Sharoni Y, Danilenko M. (2001) Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1, 25-dihydroxyvitamin D3 and retinoic acid. Nutr Cancer 41: 35-144.
17. Huang SC, Ho CT, Lin-Shiau SY, Lin JK. (2005) Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 trough down-regulating nuclear factor-kappa B and c-Jun. Biochem. Pharmacol 69: 221-232. PMID: 15627474
18. Sharabani H, Izumchenko E, Wang Q, Kreinin R, Steiner M, Barvish Z, et al. (2006) Cooperative effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia. Int J Cancer 118: 3012-3021. PMID: 16395705
19. Shabtay A, Sharabani H, Barvish Z, Kafka M, Amichay D, Levy J, et al. (2008) Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia. Oncology 75: 203-214. doi: 10.1159/000163849 PMID: 18852491
20. Moran AE, Carothers AM, Weyant MJ, Redston M, Bertagnolli MM. (2005) Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+ (Min/+) mouse. Cancer Res 65:1097-1104. PMID: 15705912
21. HuangMT, Ho CT, Wang ZY, Ferraro T, Lou YR, Stauber K, et al. (1994) Inhibition of skin tumorigenesis by rosemary and its constituent carnosol and ursolic acid. Cancer Res 54: 701-708. PMID: 8306331
22. Singletary KW, MacDonald C, Wallig M. (1996) Inhibition by rosemary and carnosol of 7, 12 dimethylbenz[ a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA/DNA adduct formation. Cancer Lett 104: 43-48. PMID: 8640744
23. Singletary KW, Rokusek JT. (1996) Tissue-specific enhancement of xenobiotic detoxification enzymes in mice by dietary rosemary extract. Plant Foods Human Nutr 50: 47-53.
24. Offord EA, Mace K, Ruffieux C,Malnoe A, Pfeifer AMA. (1995) Rosemary components inhibit benzo[a] pyrene-induced genotoxicity in human bronchial cells. Carcinogenesis 16: 2057-2062. PMID: 7554054
25. Offord EA, Mace K, Avanti O, Pfeifer AMA. (1997) Mechanism involved in the chemoprotective effects of rosemary extract studied in human liver and bronchial cells. Cancer Lett 144: 275-281.
26. Sun W, Schuchter LM. (2001) Metastatic melanoma. Curr Treat Options Oncol 2: 193-202. PMID: 12057119
27. Marugame T, Zhang MJ. (2010) Comparison of time trends in melanoma of skin cancer mortality (1990-2006) between countries based on the WHO mortality database. Jpn J Clin Oncol 40: 710. doi: 10.1093/jjco/hyq107 PMID: 20587618
28. Atallah E, Flaherty L. (2005) Treatment of metastatic malignant melanoma. Curr Treat Options Oncol 6: 185-193. PMID: 15869730
29. Tawbi HA, Buch SC. (2010) Chemotherapy resistance abrogation in metastatic melanoma. Clin Adv Hematol Oncol 8: 259-266. PMID: 20505649
30. Pappin DJ. (2003) Peptide mass fingerprinting using MALDI-ToF mass spectrometry. Methods Mol Biol 211: 211-219. PMID: 12489433
31. Herrero M, Plaza M, Cifuentes A, Ibáñez E. (2010) Green processes for the extraction of bioactives from Rosemary: Chemical and functional characterization via ultra-performance liquid chromatography-tandem mass spectrometry and in-vitro assays. J. Chromatogr A, 1217: 2512-2520. doi: 10.1016/j.chroma.2009.11.032 PMID: 19945706
32. Qu J, Wang Y, Luo G. (2001) Determination of scutellarin in Erigeron breviscapus extract by liquid chromatography - Tandem mass spectrometry. J. of Chromatogr A, 919: 437-441.
33. Señoráns FJ, Ibañez E, Cavero S, Tabera J, Reglero G. (2000) Liquid chromatographic - Mass spectrometric analysis of supercritical-fluid extracts of rosemary plants. J. Chromatogr. A, 870: 491-499. PMID: 10722107
34. Ding HY, Chou TH, Liang CH. (2010) Antioxidant and antimelanogenic properties of rosmarinic acid methyl ester from Origanum vulgare. Food Chemistry 123: 254-262.
35. Russo A, Lombardo L, Troncoso N, Garbarino J, Cardile V. (2009) Rosmarinus officinalis extract inhibits human melanoma cell growth. Nat Prod Commun 4: 1707-10. PMID: 20120112
36. Liao Y, Shen W, Kong G, Lv H, Tao W, Bo P. Apigenin induces the apoptosis and regulates MAPK signaling pathways in mouse macrophage ANA-1 cells. (2014) PLoS One 19: e92007.
37. Bai H, Jin H, Yang F, Zhu H, Cai J. Apigenin induced MCF-7 cell apoptosis-associated reactive oxygen species. (2014) Scanning 36: 622-31. doi: 10.1002/sca.21170 PMID: 25327419
38. Yang B, Zhao YL, Yang X, Liao XL, Yang J, Zhang JH, et al. (2013) Scutellarin-cyclodextrin conjugates: synthesis, characterization and anticancer activity. Carbohydrate Polymers 92: 1308-14. doi: 10.1016/j.carbpol.2012.10.012 PMID: 23399159
39. Johnson JJ, Syed DN, Heren CR, Suh Y, Adhami VM, Mukhtar H. (2008) Carnosol, a dietary diterpene, displays growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5'-AMP-activated protein kinase (AMPK) pathway. Pharm Res 25: 2125-34. doi: 10.1007/s11095-008-9552-0 PMID: 18286356
40. Visanji JM, Thompson DG, Padfield PJ. (2006) Induction of G2/M phase cell cycle arrest by carnosol and carnosic acid is associated with alteration of cyclin A and cyclin B1 levels. Cancer Letters 237: 130-36. PMID: 16019137
41. Lin Y, Shi R, Wang X, Shen HM. (2008) Luteolin, a flavonoid with potentials for cancer prevention and therapy. Curr Cancer Drug Targets 8: 634-46. PMID: 18991571
42. Wang F, Gao F, Pan S, Zhao S, Xue Y. (2014) Luteolin induces apoptosis, G0/G1 cell cycle arrest and mitochondrial membrane potential loss in neuroblastoma brain tumor cells. Drug Res [Epub ahead of print] PMID: 24831243.
43. George VC, Naveen Kumar DR, Suresh PK, Kumar S, Kumar RA. (2013) Comparative studies to evaluate relative in vitro potency of luteolin in inducing cell cycle arrest and apoptosis in HaCaT and A375 cells. Asian Pac J Cancer Prev 14: 631-637. PMID: 23621210
44. Das S, Das J, Samadder A, Boujedaini N, Khuda-Bukhsh AR. (2012) Apigenin-induced apoptosis in A375 and A549 cells through selective action and dysfunction of mitochondria. Exp Biol Med 237:1433-1448.
45. Ulrich-Merzenich G, Panek D, Zeitler H, Wagner H, Vetter H. (2009) New perspectives for synergy research with the "omic" technologies. Phytomedicine 16: 495-508. doi: 10.1016/j.phymed.2009.04. 001 PMID: 19428231
46. Visanji JM, Thompson DG, Padfield PJ. (2006) Induction of G2/M arrest by carnosol and carnosic acid is associated with alteration of cyclin A and cyclin B levels. Cancer Lett 237: 130-136. PMID: 16019137
47. Choi EJ, Kim GH. (2013) O-desmethylangolensin inhibits the proliferation of human breast cancer MCF-7 cells by inducing apoptosis and promoting cell cycle arrest. Oncol Lett 6: 1784-88. PMID: 24260076
48. Zhang J, Zhu X, Li H, Li B, Sun L, Xie T, et al. (2014) Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression. Int Immunopharmacol 20: 50-58.
49. Rieder CL, Maiato H. (2004) Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 7: 637-51. PMID: 15525526
50. Ullah MF, Ahmad A, Khan HY, Zubair H, Sarkar FH, Hadi SM. (2013) The prooxidant action of dietary antioxidants leading to cellular DNA breakage and anticancer effects: implications for chemotherapeutic action against cancer. Cell Biochem Biophys 67: 431-438. doi: 10.1007/s12013-011-9303-4 PMID: 22038302
51. Benham A. M., (2012), The protein disulfide-isomerase family: key players in health and disease. Antioxid Redox Signal 16: 781-789 doi: 10.1089/ars.2011.4439 PMID: 22142258
52. Xu S, Sankar S, Neamati N. (2014) Protein disulfide-isomerase: a promising target for cancer therapy. Drug Discov Today 19: 222-40. doi: 10.1016/j.drudis.2013.10.017 PMID: 24184531
53. Higa A, Taouji S, Lhomond S, Jensen D, Fernandez-Zapico ME, Simpson JC,et al. (2014) Endoplasmic reticulum stress-activated transcription factor ATF6α requires the disulfide-isomerase PDIA5 to modulate chemoresistance. Mol Cell Biol 34: 1839-49. doi: 10.1128/MCB.01484-13 PMID: 24636989
54. Ménoret A, Drew DA, Miyamoto S, Nakanishi M, Vella AT, Rosenberg DW. (2014) Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells. Mol Carcinog 53 Suppl 1: E11-22. doi: 10.1002/mc.21986 PMID: 23255428
55. Lovat PE, Corazzari M, Armstrong JL, Martin S, Pagliarini V, Hill D, et al. (2008) Increasing melanoma cell death using inhibitors of protein disulfide-isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Res 68: 5363-5369. doi: 10.1158/0008-5472.CAN-08-0035 PMID: 18593938
56. Trombetta ES, Simons JF, Helenius A. (1996); Endoplasmic reticulum glucosidase II is composed of a catalytic subunit, conserved from yeast to mammals, and a highly bound noncatalytic HDEL-containing subunit. J Biol Chem 271: 27509-16. PMID: 8910335
57. D'Alessio C, Fermandez F, Trombetta ES, Parodi AJ. (1999) Genetic evidence for the heterodimeric structure of glucosidase. II. The effect of disrupting the subunit-encoding genes on glycoprotein folding. J Biol Chem 274: 25899-905. PMID: 10464333
58. Park SJ, Kim SH, Choi HS, Rhee Y, Lim SK. (2009) Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNAsynthetase promotes survival of osteoblasts by regulating anti-apoptotic PI3K/Aktsignaling. Bone 45: 994-1003 doi: 10.1016/j.bone.2009.07.018 PMID: 19631775
59. Drenth JP, Martina JA, van de Kerkhof R, Bonifacino JS, Jansen JB. (2005) Polycystic liver disease is a disorder of cotranslational protein processing. Trends Mol Med 11: 37-42. PMID: 15649821
60. Chiu CC, Lin CY, Lee LY, Chen YJ, Lu YC, Wang HM et al. (2011) Molecular chaperones as a common set of proteins that regulate the invasion phenotype of head and neck cancer. Clin Cancer Res 17: 4629-41. doi: 10.1158/1078-0432.CCR-10-2107 PMID: 21642380
61. Han W, Xin Z, Zhao Z, Bao W, Lin X, Yin B, et al. (2013) RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3. J Clin Invest 123: 2103-18. doi: 10.1172/JCI61820 PMID: 23585479
62. Hu CE, Liu YC, Zhang HD, Huang GJ. (2014) The RNA-binding protein PCBP2 facilitates gastric carcinoma growth by targeting miR-34a. Biochem Biophys Res Commun 448: 437-42. doi: 10.1016/j.bbrc. 2014.04.124 PMID: 24796666
63. Molinaro RJ, Jha BK, Malathi K, Varambally S, Chinnaiyan AM, Silverman RH (2006) Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells. Nucleic Acids Res 34: 6684-95. PMID: 17145707
64. Chang JS, Santhanam R, Trotta R, Neviani P, Eiring AM, Briercheck E, et al. (2007) High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C7EBPalphadriven myeloid differentiation. Blood 110: 994-1003. PMID: 17475908
65. Cho NH, Koh ES, Lee DW, Kim H, Choi YP, Cho SH, et al. (2006) Comparative proteomics of pulmonary tumors with neuroendocrine differentiation. J Proteome Res 5: 643-50. PMID: 16512680
66. Zhavoronkov A, Smit-McBride Z, Guinan KJ, Litovchenko M, Moskalev A. (2012) Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases. J Mol Med 90: 1361-89. doi: 10.1007/s00109-012-0962-4 PMID: 23090008
67. Yu SG, Hildebrandt LA, Elson CE. (1995) Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice. J Nutr 125: 2763-7. PMID: 7472655